Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

CpG-7909 enters phase I/II in malignant melanoma

June 17, 2002

G17DT plus chemotherapy gives encouraging results in metastatic stomach cancer

June 14, 2002

Product R cleared for Israeli phase I study in leukemia and lymphoma

June 14, 2002

Pharmexa updates AutoVac HER-2 DNA pharmaccine trial progress

June 13, 2002

Medarex and IDM partner to develop Cell Drugs in combination with MDX-010

June 13, 2002

KW-2871 enters malignant melanoma study

June 13, 2002

GVAX cancer vaccines highlighted at the ASGT meeting

June 12, 2002

ING-1 suitable for further evaluation according to initial human study

June 7, 2002

Promising phase I results with ISF-154 lead to initiation of phase II trial in CLL

June 7, 2002

Virulizin granted fast track designation in pancreatic cancer

June 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...